×
About 7,895 results

ALLMedicine™ Sarcoidosis Center

Research & Reviews  2,640 results

A 40-Year-Old Man with Sarcoidosis and Factor V Leiden Thrombophilia Presenting with De...
https://doi.org/10.12659/AJCR.932286
The American Journal of Case Reports; Goljan-Geremek A, Puścińska E et. al.

Jul 31st, 2021 - BACKGROUND The association between sarcoidosis and pulmonary embolism (PE) has been described in the literature, but little is known about the origin of hypercoagulability and hypofibrinolysis in sarcoidosis. PE is a multifactorial disease that is...

HLA-DRB1 alleles associate with hypercalcemia in sarcoidosis.
https://doi.org/10.1016/j.rmed.2021.106537
Respiratory Medicine; Werner J, Rivera N et. al.

Jul 30th, 2021 - The mechanisms behind and which patients are at risk of developing sarcoidosis associated hypercalcemia (SAHC) have not been addressed. Different human leukocyte antigen (HLA) alleles associate with disease phenotypes in sarcoidosis. Insights into...

Outcomes of SARS-CoV-2 infection in patients with pulmonary sarcoidosis: A multicenter ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297986
Respiratory Medicine; Hadi YB, Lakhani DA et. al.

Jul 30th, 2021 - Analyses of COVID-19 infection outcomes in patients with preexisting pulmonary sarcoidosis are lacking and are limited to case reports or small case series with the largest study reporting outcomes of 37 patients. Retrospective cohort study to ass...

Rituximab for the Treatment of Refractory Cardiac Sarcoidosis-A Single Center Experience.
https://doi.org/10.1016/j.cardfail.2021.07.008
Journal of Cardiac Failure; Elwazir M, Krause ML et. al.

Jul 29th, 2021 - To examine the effect of anti-B cell therapy (rituximab) on cardiac inflammation and function in corticosteroid-refractory cardiac sarcoidosis. Cardiac sarcoidosis (CS) is a rare cause of cardiomyopathy characterized by granulomatous inflammation ...

Unusual organ involvement in sarcoidosis: sarcoid myopathy and peritoneal sarcoidosis.
https://doi.org/10.1136/bcr-2021-244134
BMJ Case Reports; Itagane M, Kinjo M

Jul 29th, 2021 - Myopathy and peritoneal involvement are rare complications of sarcoidosis, and the latter can mimic malignancy with peritoneal dissemination. In this case, a patient with a history of polyarthritis and positive rheumatoid factor presented with pro...

see more →

Guidelines  3 results

Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159433
American Journal of Respiratory and Critical Care Medicine; Crouser ED, Maier LA et. al.

Apr 16th, 2020 - Background: The diagnosis of sarcoidosis is not standardized but is based on three major criteria: a compatible clinical presentation, finding nonnecrotizing granulomatous inflammation in one or more tissue samples, and the exclusion of alternativ...

2019 HRS expert consensus statement on evaluation, risk stratification, and management ...
https://doi.org/10.1016/j.hrthm.2019.05.007
Heart Rhythm; Towbin JA, McKenna WJ et. al.

May 13th, 2019 - Arrhythmogenic cardiomyopathy (ACM) is an arrhythmogenic disorder of the myocardium not secondary to ischemic, hypertensive, or valvular heart disease. ACM incorporates a broad spectrum of genetic, systemic, infectious, and inflammatory disorders....

Consensus statement on surgical pathology of the aorta from the Society for Cardiovascu...
https://doi.org/10.1016/j.carpath.2015.05.001
Cardiovascular Pathology : the Official Journal of the So... Stone JR, Bruneval P et. al.

Jun 9th, 2015 - Inflammatory diseases of the aorta include routine atherosclerosis, aortitis, periaortitis, and atherosclerosis with excessive inflammatory responses, such as inflammatory atherosclerotic aneurysms. The nomenclature and histologic features of thes...

see more →

Drugs  236 results see all →

Clinicaltrials.gov  88 results

Role of Genetic Factors in the Development of Lung Disease
https://clinicaltrials.gov/ct2/show/NCT00001532

May 4th, 2020 - This study is designed to evaluate genetic mechanisms of lung disease by surveying polymorphic genes involved in respiratory function and examining gene expression in the lung cells of individuals with pulmonary disease (e.g., alpha 1-antitrypsin ...

Acthar Gel in Participants With Pulmonary Sarcoidosis
https://clinicaltrials.gov/ct2/show/NCT03320070

May 1st, 2020 - 07-Apr-2020: This trial is continuing for enrolled participants. Recruiting for new participants has stopped at all sites because of COVID-19. Overall Recruitment Status is "Active, Not Recruiting". The Actual Number of Participants is still "Anti...

A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or Sarcoidosis
https://clinicaltrials.gov/ct2/show/NCT03727451

Apr 24th, 2020 - A phase 2b, open label study to assess the hemodynamic effects of increasing doses of pulsed, inhaled nitric oxide (iNO) in subjects with pulmonary hypertension associated with pulmonary fibrosis or sarcoidosis on long term oxygen therapy followed...

Somatostatin Receptor Imaging in Patients With Suspected Cardiac Sarcoidosis
https://clinicaltrials.gov/ct2/show/NCT02546388

Apr 9th, 2020 - The purpose of this research study to find out if a drug called OctreoScan or DOTATATE can help doctors diagnose people with cardiac sarcoidosis better. OctreoScan and DOTATATE are both approved by the U.S. Food and Drug Administration (FDA) to di...

Study Comparing Two Different Methods of Cryobiopsy in the Interstitial Lung Diseases
https://clinicaltrials.gov/ct2/show/NCT03727568

Mar 24th, 2020 - Design: The investigators design a prospective randomised multicenter study to assess the diagnostic value of cryobiopsy in patients with suspected Idiopathic Interstitial Pneumonia by comparing two different interventional methods. Patients with ...

see more →

News  178 results

Tofacitinib: Small Study Shows Big Cutaneous Sarcoidosis Response
https://www.medscape.com/viewarticle/950598

May 5th, 2021 - Researchers are reporting impressive results in a small, open-label trial of the JAK inhibitor tofacitinib in cutaneous sarcoidosis: 6 of 10 patients improved so much that they reached a disease activity level of zero, and all patients improved by...

Suspect Sarcoidosis? Here's What to Assess
https://www.medscape.com/viewarticle/948848

Apr 28th, 2021 - This transcript has been edited for clarity. Matthew F. Watto, MD: We are back. This is The Curbsiders. I'm Dr Matthew Watto, here with my good friend, Dr Paul Williams. We're going to talk about sarcoidosis. We had a wonderful conversation with t...

Black Patients With Cutaneous Sarcoidosis May Have More Systemic and CV Disease
https://www.medscape.com/viewarticle/949418

Apr 16th, 2021 - Black patients diagnosed by dermatologists with cutaneous sarcoidosis were significantly more likely to have unrecognized systemic organ involvement than were non-Black patients, according to a retrospective chart review of patients seen at Massac...

Fired for Good Judgment a Sign of Physicians' Lost Respect
https://www.medscape.com/viewarticle/946286

Feb 23rd, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's  Coronavirus Resource Center. What happened to Hasan Gokal, MD, should stick painfully in the craws of all physicians. It should serve as a call to action because Gokal is sit...

Checkpoint Inhibitor Safety in Preexisting Autoimmune Diseases
https://www.medscape.com/viewarticle/945979

Feb 17th, 2021 - Patients with advanced melanoma and preexisting autoimmune diseases (AIDs) who were treated with immune checkpoint inhibitors (ICIs) responded well and did not suffer more grade 3 or higher immune-related adverse events than patients without an AI...

see more →

Patient Education  13 results see all →